According to Frank Austin Nothaft, GTM lead for Genomics, Databricks, a unified approach to big data is the best way to get the most value. Here, he tells us more.
With the cost of sequencing dropping dramatically over the last decade, genomic data volumes have grown exponentially. By 2020, genomic data is expected to be reaching upwards of 40 exabytes per year.1 Pharmaceutical companies are rushing to tap into this genomic data goldmine in hopes of accelerating the costly long-tail of drug development.